CA Stock MarketDetailed Quotes

APS Aptose Biosciences Inc

Watchlist
  • 0.250
  • 0.0000.00%
15min DelayMarket Closed Nov 29 16:00 ET
14.88MMarket Cap-63P/E (TTM)

Aptose Biosciences Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1.52%-10.38M
57.21%-5.78M
-4.08%-11.76M
-37.96%-44.59M
-7.03%-9.26M
-50.97%-10.54M
-91.61%-13.5M
-17.18%-11.3M
25.36%-32.32M
46.08%-8.65M
Net income from continuing operations
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
Operating gains losses
----
--66K
--10K
----
----
----
----
----
385.71%20K
366.67%16K
Depreciation and amortization
-13.51%96K
-10.53%102K
-16.79%109K
-11.74%466K
10.00%110K
-21.28%111K
-19.15%114K
-10.27%131K
-15.11%528K
-38.65%100K
Unrealized gains and losses of investment securities
--0
-50.00%1K
75.00%-1K
----
----
-114.29%-1K
--2K
---4K
----
----
Remuneration paid in stock
-102.17%-13K
-73.08%207K
-56.83%809K
-29.84%3.65M
-52.26%411K
-43.11%599K
-1.28%769K
-25.46%1.87M
-59.79%5.21M
-62.79%861K
Other non cashItems
171.43%15K
-84.48%9K
40.00%28K
45.36%-312K
51.11%-329K
-125.61%-21K
141.67%58K
600.00%20K
-108.19%-571K
-109.70%-673K
Change In working capital
-1,678.92%-3.52M
443.53%1.09M
-971.95%-3.08M
-34.91%2.81M
137.06%2.5M
-85.28%223K
-112.34%-317K
142.94%353K
184.76%4.32M
193.28%1.06M
-Change in prepaid assets
1,017.24%324K
80.06%560K
-3.91%246K
50.87%261K
73.72%-385K
-96.48%29K
-48.08%311K
19.63%256K
121.79%173K
-1.60%-1.47M
-Change in payables and accrued expense
-935.21%-2.97M
207.39%567K
-2,511.54%-3.14M
-32.24%2.89M
45.30%2.94M
-66.16%355K
-124.86%-528K
114.05%130K
195.98%4.27M
2,061.17%2.02M
-Change in other current assets
-1,645.45%-768K
247.27%81K
-177.89%-74K
-176.61%-343K
-480.90%-339K
80.44%-44K
-175.00%-55K
196.88%95K
-3,000.00%-124K
4,550.00%89K
-Change in other current liabilities
4.27%-112K
-164.44%-119K
10.16%-115K
----
----
12.69%-117K
66.42%-45K
10.49%-128K
----
----
Cash from discontinued investing activities
Operating cash flow
1.52%-10.38M
57.21%-5.78M
-4.08%-11.76M
-37.96%-44.59M
-7.03%-9.26M
-50.97%-10.54M
-91.61%-13.5M
-17.18%-11.3M
25.36%-32.32M
46.08%-8.65M
Investing cash flow
Cash flow from continuing investing activities
0
202.50%2.01M
32.74%-1.99M
-66.87%9.96M
-88.97%1.94M
355.08%12.95M
-119.47%-1.96M
-139.44%-2.96M
185.40%30.07M
187.82%17.57M
Net PPE purchase and sale
--0
158.62%17K
--1K
-20.83%-29K
--0
--0
-20.83%-29K
--0
88.68%-24K
--0
Net investment purchase and sale
--0
203.16%1.99M
32.70%-1.99M
-66.80%9.99M
-88.97%1.94M
355.08%12.95M
-119.14%-1.93M
-139.44%-2.96M
185.98%30.09M
187.88%17.57M
Cash from discontinued investing activities
Investing cash flow
--0
202.50%2.01M
32.74%-1.99M
-66.87%9.96M
-88.97%1.94M
355.08%12.95M
-119.47%-1.96M
-139.44%-2.96M
185.40%30.07M
187.82%17.57M
Financing cash flow
Cash flow from continuing financing activities
104.16%10.01M
330.62%4.75M
23,594.00%11.85M
5,856.90%6.91M
1,574.51%854K
23,242.86%4.9M
3,706.90%1.1M
233.33%50K
-48.67%116K
-22.73%51K
Net issuance payments of debt
--10M
----
----
----
----
--0
----
----
----
----
Net common stock issuance
--0
344.63%4.93M
34,691.18%11.83M
6,712.87%6.88M
1,652.94%894K
22,966.67%4.84M
3,724.14%1.11M
--34K
180.56%101K
41.67%51K
Proceeds from stock option exercised by employees
-38.46%8K
--0
12.50%18K
93.33%29K
--0
--13K
--0
6.67%16K
-92.11%15K
--0
Net other financing activities
----
-3,440.00%-177K
----
----
----
--45K
---5K
----
----
----
Cash from discontinued financing activities
Financing cash flow
104.16%10.01M
330.62%4.75M
23,594.00%11.85M
5,856.90%6.91M
1,574.51%854K
23,242.86%4.9M
3,706.90%1.1M
233.33%50K
-48.67%116K
-22.73%51K
Net cash flow
Beginning cash position
-0.83%8.33M
-67.73%7.35M
-74.97%9.25M
-5.48%36.97M
-43.84%15.72M
-79.02%8.4M
-38.47%22.76M
-5.48%36.97M
-66.68%39.11M
-62.73%27.99M
Current changes in cash
-105.03%-368K
106.86%985K
86.58%-1.91M
-1,195.33%-27.72M
-172.07%-6.47M
160.81%7.32M
-571.10%-14.36M
-568.80%-14.21M
97.27%-2.14M
124.93%8.97M
Effect of exchange rate changes
--0
66.67%-1K
-75.00%1K
150.00%2K
-116.67%-1K
114.29%1K
40.00%-3K
100.00%4K
-157.14%-4K
-14.29%6K
End cash Position
-49.35%7.96M
-0.83%8.33M
-67.73%7.35M
-74.97%9.25M
-74.97%9.25M
-43.84%15.72M
-79.02%8.4M
-38.47%22.76M
-5.48%36.97M
-5.48%36.97M
Free cash from
1.52%-10.38M
57.30%-5.78M
-4.08%-11.76M
-37.94%-44.62M
-7.03%-9.26M
-50.97%-10.54M
-91.37%-13.53M
-17.18%-11.3M
25.67%-32.35M
46.13%-8.65M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1.52%-10.38M57.21%-5.78M-4.08%-11.76M-37.96%-44.59M-7.03%-9.26M-50.97%-10.54M-91.61%-13.5M-17.18%-11.3M25.36%-32.32M46.08%-8.65M
Net income from continuing operations 39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M
Operating gains losses ------66K--10K--------------------385.71%20K366.67%16K
Depreciation and amortization -13.51%96K-10.53%102K-16.79%109K-11.74%466K10.00%110K-21.28%111K-19.15%114K-10.27%131K-15.11%528K-38.65%100K
Unrealized gains and losses of investment securities --0-50.00%1K75.00%-1K---------114.29%-1K--2K---4K--------
Remuneration paid in stock -102.17%-13K-73.08%207K-56.83%809K-29.84%3.65M-52.26%411K-43.11%599K-1.28%769K-25.46%1.87M-59.79%5.21M-62.79%861K
Other non cashItems 171.43%15K-84.48%9K40.00%28K45.36%-312K51.11%-329K-125.61%-21K141.67%58K600.00%20K-108.19%-571K-109.70%-673K
Change In working capital -1,678.92%-3.52M443.53%1.09M-971.95%-3.08M-34.91%2.81M137.06%2.5M-85.28%223K-112.34%-317K142.94%353K184.76%4.32M193.28%1.06M
-Change in prepaid assets 1,017.24%324K80.06%560K-3.91%246K50.87%261K73.72%-385K-96.48%29K-48.08%311K19.63%256K121.79%173K-1.60%-1.47M
-Change in payables and accrued expense -935.21%-2.97M207.39%567K-2,511.54%-3.14M-32.24%2.89M45.30%2.94M-66.16%355K-124.86%-528K114.05%130K195.98%4.27M2,061.17%2.02M
-Change in other current assets -1,645.45%-768K247.27%81K-177.89%-74K-176.61%-343K-480.90%-339K80.44%-44K-175.00%-55K196.88%95K-3,000.00%-124K4,550.00%89K
-Change in other current liabilities 4.27%-112K-164.44%-119K10.16%-115K--------12.69%-117K66.42%-45K10.49%-128K--------
Cash from discontinued investing activities
Operating cash flow 1.52%-10.38M57.21%-5.78M-4.08%-11.76M-37.96%-44.59M-7.03%-9.26M-50.97%-10.54M-91.61%-13.5M-17.18%-11.3M25.36%-32.32M46.08%-8.65M
Investing cash flow
Cash flow from continuing investing activities 0202.50%2.01M32.74%-1.99M-66.87%9.96M-88.97%1.94M355.08%12.95M-119.47%-1.96M-139.44%-2.96M185.40%30.07M187.82%17.57M
Net PPE purchase and sale --0158.62%17K--1K-20.83%-29K--0--0-20.83%-29K--088.68%-24K--0
Net investment purchase and sale --0203.16%1.99M32.70%-1.99M-66.80%9.99M-88.97%1.94M355.08%12.95M-119.14%-1.93M-139.44%-2.96M185.98%30.09M187.88%17.57M
Cash from discontinued investing activities
Investing cash flow --0202.50%2.01M32.74%-1.99M-66.87%9.96M-88.97%1.94M355.08%12.95M-119.47%-1.96M-139.44%-2.96M185.40%30.07M187.82%17.57M
Financing cash flow
Cash flow from continuing financing activities 104.16%10.01M330.62%4.75M23,594.00%11.85M5,856.90%6.91M1,574.51%854K23,242.86%4.9M3,706.90%1.1M233.33%50K-48.67%116K-22.73%51K
Net issuance payments of debt --10M------------------0----------------
Net common stock issuance --0344.63%4.93M34,691.18%11.83M6,712.87%6.88M1,652.94%894K22,966.67%4.84M3,724.14%1.11M--34K180.56%101K41.67%51K
Proceeds from stock option exercised by employees -38.46%8K--012.50%18K93.33%29K--0--13K--06.67%16K-92.11%15K--0
Net other financing activities -----3,440.00%-177K--------------45K---5K------------
Cash from discontinued financing activities
Financing cash flow 104.16%10.01M330.62%4.75M23,594.00%11.85M5,856.90%6.91M1,574.51%854K23,242.86%4.9M3,706.90%1.1M233.33%50K-48.67%116K-22.73%51K
Net cash flow
Beginning cash position -0.83%8.33M-67.73%7.35M-74.97%9.25M-5.48%36.97M-43.84%15.72M-79.02%8.4M-38.47%22.76M-5.48%36.97M-66.68%39.11M-62.73%27.99M
Current changes in cash -105.03%-368K106.86%985K86.58%-1.91M-1,195.33%-27.72M-172.07%-6.47M160.81%7.32M-571.10%-14.36M-568.80%-14.21M97.27%-2.14M124.93%8.97M
Effect of exchange rate changes --066.67%-1K-75.00%1K150.00%2K-116.67%-1K114.29%1K40.00%-3K100.00%4K-157.14%-4K-14.29%6K
End cash Position -49.35%7.96M-0.83%8.33M-67.73%7.35M-74.97%9.25M-74.97%9.25M-43.84%15.72M-79.02%8.4M-38.47%22.76M-5.48%36.97M-5.48%36.97M
Free cash from 1.52%-10.38M57.30%-5.78M-4.08%-11.76M-37.94%-44.62M-7.03%-9.26M-50.97%-10.54M-91.37%-13.53M-17.18%-11.3M25.67%-32.35M46.13%-8.65M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data